Genelux Corporation (GNLX)
$2.55-0.39%Close
BUYRECOVERY · day 9
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $114M
- Beta
- 0.58
- P/E (TTM)
- -2.85
- Short % float
- 12.07%
- Days to cover
- 20.4
- SI change
- +6.5%
- 1W
- -1.92%
- 1M
- +2.41%
- vs SPY 1W
- -2.35%
- vs SPY 1M
- +0.35%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on GNLX?
- LOPJLB’s latest quantitative signal on Genelux Corporation (GNLX) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is GNLX in?
- Genelux Corporation (GNLX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Genelux Corporation (GNLX) do?
- Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patients confronting aggressive and/or hard-to-treat solid tumor malignancies. Its leading experimental drug, Olvi-Vec, is a proprietary, engineered vaccinia virus strain being developed to address ovarian cancer and non-small cell lung cancer. The company is also…